Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
Showing 1 - 2 of 2 results
News || 3 min read
Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab
Press Release || 4 min read